Godoy-Santos Alexandre Leme, de Cesar Cesar, Santini Simone, Herrera-Pérez Mario, Valderrabano Victor, Rammelt Stefan
Universidade de São Paulo, Faculdade de Medicina, Hospital das Clínicas HC-FMUSP, Laboratório Prof Manlio Mario Marco Napoli, São Paulo, SP, Brazil.
Hospital Israelita Albert Einstein, Sao Paulo, SP, Brazil.
Acta Ortop Bras. 2024 Jul 22;32(3):e282286. doi: 10.1590/1413-785220243203e282286. eCollection 2024.
Besides the acute injury and trauma-induced macroscopic alterations, the evolution to posttraumatic ankle osteoarthritis (PTOA) is a complex process progressing at the tissue and molecular level. Furthermore, changes in the molecular pathways affect chondrocyte viability. Treatment modalities for PTOA focal or confined disease include innovative techniques.
Our purpose is to increase medical awareness based on scientific evidence of pathophysiology, molecular biology, and treatment of post-traumatic ankle osteoarthritis.
To support the perspectives of the experts, evidence from the scientific literature respected the PRISMA guidelines and the PICOS search strategy was used. We included case-control, cohort, experimental studies and case reports, written in English.
The authors were homogeneously exposed to 282 selected abstracts and 114 full articles directly related to post-traumatic osteoarthritis after malleolar fractures.
The pathophysiological factors involved in posttraumatic ankle osteoarthritis, such as biological, structural, mechanical, and molecular changes must be studied together, as the interaction between these factors determines the risk of progression of PTOA. Inhibition of a single catabolic molecule or cascade probably is not sufficient to alter the natural progression of the pathological process.
除急性损伤和创伤引起的宏观改变外,创伤后踝关节骨关节炎(PTOA)的演变是一个在组织和分子水平上进展的复杂过程。此外,分子途径的变化会影响软骨细胞的活力。PTOA局灶性或局限性疾病的治疗方式包括创新技术。
我们的目的是基于创伤后踝关节骨关节炎病理生理学、分子生物学和治疗的科学证据,提高医学认知。
为支持专家观点,科学文献证据遵循PRISMA指南,并采用PICOS检索策略。我们纳入了用英文撰写的病例对照、队列、实验研究和病例报告。
作者们统一接触了282篇选定的摘要和114篇与踝关节骨折后创伤性骨关节炎直接相关的全文。
创伤后踝关节骨关节炎所涉及的病理生理因素,如生物学、结构、力学和分子变化,必须一起研究,因为这些因素之间的相互作用决定了PTOA进展的风险。抑制单个分解代谢分子或级联反应可能不足以改变病理过程的自然进展。